Presumably the 5-month duration was based on the date of their 2020 submission for FDA EUA approval, relative to the earliest date of infection of their test subjects. If those early test subjects are participating in the ongoing trial of T-Detect, it's now probably a year since their infection & recovery. Hopefully we'll see a longer duration in their next FDA submission.